July 31, 2026 The Critical Path Institute Podcast: How C-Path’s Accelerator Is Impacting Tomorrow’s Medicines This episode of the Critical Path Institute podcast features Maaike Everts, Executive Director of C-Path’s Translational The
July 29, 2026 Scaling the Science: The Maturation of NAMs and the Demand for Validated Scaling The commercial and regulatory reality of New Approach Methodologies (NAMs) materialized rapidly this conference season.
July 14, 2026 Karen Bernstein, One of Biotech’s Most Influential Voices, Elected C-Path Board Chair TUCSON, Ariz., July 14, 2026 — Critical Path Institute® (C-Path) today announced that its Board of Directors has elected...
July 29, 2026 eCOA Consortium and PCE Consortium Webinar Recording: Event Driven eDiaries At C-Path’s 2026 Clinical Outcome Assessment Program Annual Meeting, attendees heard a brief overview of...
June 5, 2026 Public Private Partnerships for Rare Neurodegenerative Disease Webinar Recording Available Critical Path Institute's Critical Path for Rare Neurodegenerative Diseases consortium, will convene partners from the FDA...
May 14, 2026 The Critical Path Institute Podcast: Accelerating Drug Development in Friedreich’s Ataxia, with Ron Bartek The newest Critical Path Institute® (C-Path) podcast features Ron Bartek, president and co-founder of the Friedreich’s Ataxia
May 13, 2026 Electroencephalography during acute painful procedures in neonates: a scoping review Although electroencephalography (EEG) is used to assess neonatal pain in research settings, EEG assessments...
April 28, 2026 Electroencephalography During Acute Painful Procedures in Neonates: a Scoping Review Although electroencephalography (EEG) is used to assess neonatal pain in research settings...
April 8, 2026 Webinar Recording Available: Scalable Approaches to Patient-Centered Benefit–Risk: Defining Patient-Focused Drug Development in Precision Medicine As precision medicine advances, approaches to benefit–risk must evolve beyond traditional models designed...
April 1, 2026 Advancing Rare Disease Innovation Through Responsible Data Sharing — Key Takeaways from the RISE Together: Data Sharing Across the Rare Disease Ecosystem At a recent public workshop co-convened by the Duke-Margolis Institute for Health Policy...
